20-33686031-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_005225.3(E2F1):āc.234G>Cā(p.Ala78=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000267 in 1,133,460 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.0012 ( 0 hom., cov: 32)
Exomes š: 0.00012 ( 1 hom. )
Consequence
E2F1
NM_005225.3 synonymous
NM_005225.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.07
Genes affected
E2F1 (HGNC:3113): (E2F transcription factor 1) The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionally conserved domains found in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. This protein and another 2 members, E2F2 and E2F3, have an additional cyclin binding domain. This protein binds preferentially to retinoblastoma protein pRB in a cell-cycle dependent manner. It can mediate both cell proliferation and p53-dependent/independent apoptosis. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 20-33686031-C-G is Benign according to our data. Variant chr20-33686031-C-G is described in ClinVar as [Benign]. Clinvar id is 734667.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-1.07 with no splicing effect.
BS2
High AC in GnomAd4 at 183 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
E2F1 | NM_005225.3 | c.234G>C | p.Ala78= | synonymous_variant | 1/7 | ENST00000343380.6 | NP_005216.1 | |
E2F1 | XM_047439961.1 | c.234G>C | p.Ala78= | synonymous_variant | 1/5 | XP_047295917.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
E2F1 | ENST00000343380.6 | c.234G>C | p.Ala78= | synonymous_variant | 1/7 | 1 | NM_005225.3 | ENSP00000345571 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00122 AC: 183AN: 150006Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
183
AN:
150006
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000122 AC: 120AN: 983344Hom.: 1 Cov.: 30 AF XY: 0.000119 AC XY: 55AN XY: 462504
GnomAD4 exome
AF:
AC:
120
AN:
983344
Hom.:
Cov.:
30
AF XY:
AC XY:
55
AN XY:
462504
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00122 AC: 183AN: 150116Hom.: 0 Cov.: 32 AF XY: 0.00115 AC XY: 84AN XY: 73342
GnomAD4 genome
AF:
AC:
183
AN:
150116
Hom.:
Cov.:
32
AF XY:
AC XY:
84
AN XY:
73342
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 18, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at